1 / 52

Western States Pediatric Pulmonary Case Conference Cough, Hypoxia, and Down Syndrome

Western States Pediatric Pulmonary Case Conference Cough, Hypoxia, and Down Syndrome. Emily DeBoer, MD The Children’s Hospital University of Colorado September 22, 2010. Outline. Case presentation: Cough, Hypoxia, and Down Syndrome Differential Diagnosis

kenaz
Download Presentation

Western States Pediatric Pulmonary Case Conference Cough, Hypoxia, and Down Syndrome

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Western States Pediatric Pulmonary Case ConferenceCough, Hypoxia, and Down Syndrome Emily DeBoer, MD The Children’s Hospital University of Colorado September 22, 2010

  2. Outline Case presentation: Cough, Hypoxia, and Down Syndrome Differential Diagnosis Multi-system complications of patients with Trisomy 21 Treatment and Monitoring

  3. Chief Complaint 9 month old female with Down Syndrome referred to pulmonary clinic for initial evaluation because of cough and persistent oxygen requirement

  4. History of Present Illness • Daily cough for months - day and night • No increased work of breathing • Snoring • Gags with jejunal feeds • Treated with Ranitidine • Severe oral aversion, tastes by mouth

  5. Past medical/surgical history • Trisomy 21 • Born at 36 weeks in Colorado • Esophageal atresia without TEF • GT placment DOL 1 • Gastric pull-through at 4 months • On and off oxygen • Ventilated x 1 week after surgery • Discharged at 5 months on ¼ lpm O2 via nasal cannula

  6. PMH/PSH PDA ligation at 5 months of age Recent echo revealed – “normal function, small left to right ASD, mild TR” Monthly esophageal dilations – tolerated well

  7. Meds at visit Ranitidine Spironolactone/hydrochlorothiazide ¼ lpm oxygen No inhaled medicines No steroids

  8. Review of Systems No fevers Adequate growth No hemoptysis No vomiting No steatorrhea Normal thyroid No hematuria Sitting with support

  9. Family and Social History No asthma, allergies, or lung disease in the family Lives with mom, “adopted grandparents” in Denver Parents are from Senegal No known TB exposures No pets No smokers

  10. Physical Exam • Vitals HR 136 | RR 28 | Ht 65 cm (43%) | Wt 7.5 kg (39%) • SaO2 88% RA | SaO2 95% ¼ lpm • General: happy baby, + drooling • HEENT: Down’s facies, small nares, +rhinorrhea • Chest: Easy work of breathing, clear to auscultation, prolonged expiratory phase • CVS: RRR, normal S1 and S2, no murmur • Abd: Soft, non-tender, no hepatosplenomegaly • Ext: No clubbing • Neuro: Decreased truncal tone

  11. Chest Xray at 8 months of age

  12. What should we do?

  13. What should we do? Differential Diagnosis – cough, hypoxia Reflux / aspiration Pulmonary edema Airway anomaly / poor airway clearance Asthma Interstitial lung disease Pneumonia/infection

  14. What should we do? Differential Diagnosis – cough, hypoxia Reflux / aspiration Pulmonary edema Airway anomaly / poor airway clearance Asthma Interstitial lung disease Pneumonia/infection Because of her Down Syndrome, she is at risk for aspiration, heart disease, tracheal anomalies, obstructive sleep apnea, pulmonary hypertension

  15. Bronchoscopy COLOR COLORLESS CHARACTER HAZY NUCLEATED CELLS 910 RBC 1705 RBC MORPH NORMAL SEGS 55 LYMPHS 18 MONOCYTES 7 MACROPHAGES 17 Erythematous mucosa Copious clear secretions Mild-mod malacia of trachea and both mainstem bronchi LIPID INDEX = 0. IRON INDEX = 270. Bacterial and viral cultures: negative

  16. What should we do now? Cause of increased iron index? Treatment?

  17. Disorders with pulmonary capillaritis • Disorders without pulmonary capillaritis • Noncardiovascular • Cardiovascular • Chronic heart failure • Pulmary Hypertension • Pulmonary veno-occlusive disease

  18. Follow-up via phone • New symptoms • Rhinorrhea • Increased cough, respiratory rate • Sleeping more • Requiring ½ - 1 lpm O2 • Intervention • 5 days of oral steroids

  19. Follow-up Outpatient echocardiogram scheduled Improved for 2 weeks, then symptoms returned Treated with 5 more days oral steroids by her PCP Symptoms do not resolve – present to ED Further history – taking liquids by mouth for 6 weeks as instructed by therapy

  20. Physical Exam in ED Vitals HR 180 | RR 62 | SaO2 94% 3 lpm General: Infant in moderate respiratory distress HEENT: Down’s facies, +rhinorrhea Chest: Subcostal retractions, tachypneic, coarse symmetric breath sounds CVS: Tachycardic, prominent S2, 2/6 systolic flow murmur at LLSB Abd: Soft, non-tender, Liver down 3 cm

  21. 8 months of age 12 months of age in ED

  22. What should we do?

  23. What should we do? Differential Diagnosis – cough, hypoxemia, prominent S2, hepatomegaly Pulmonary hypertension Aspiration Heart failure Infection

  24. Laboratory • CBC • 11.6 WBC 81% Segs, 8% Lymphs, 10% Monos • Hb 16.3 g/dL / Hct 51.4 % • Platelets 221 • CBG • pH 7.43 • CO2 34 mm Hg

  25. Echocardiogram • Small secundum ASD with bidirectional flow. • Moderate right heart enlargement and moderate septal flattening. • Normal left ventricular size and systolic function. Low normal RV systolic function. • Systemic pulmonary hypertension (on 3 lpm NC O2). • TV jet 4.48 m/second • RV-RA grad 80 mm Hg (SBP 90/69)

  26. Pulmonary Hypertension Causes?

  27. Pulmonary Hypertension • Causes of secondary PAH • Cardiac/Vascular anomaly • Chronic lung disease • Trisomy 21 • Aspiration / reflux • Overcirculation from PDA (repaired at 5 months) • Obstructive sleep apnea • Thromboembolic disease • Collagen vascular disease • Thyroid disease • HIV

  28. Pulmonary Hypertension • Causes of secondary PAH • Cardiac/Vascular anomaly • Chronic lung disease • Trisomy 21 • Aspiration / reflux • Overcirculation from PDA (repaired at 5 months) • Obstructive sleep apnea • Thromboembolic disease • Collagen vascular disease • Thyroid disease • HIV

  29. Cardiac catheterization 30% FiO2 Qp/Qs = 1.25:1; Rp/Rs = 0.46 21% FiO2 Qp/Qs = 1.25:1; Rp/Rs = 0.64 100% FiO2 with 40 ppm iNO Qp/Qs = 1.14:1; Rp/Rs = 0.47

  30. Pulmonary Hypertension • Causes of secondary PAH • Cardiac/Vascular anomaly • Chronic lung disease • Trisomy 21 • Aspiration / reflux • Overcirculation from PDA (repaired at 5 months) • Obstructive sleep apnea • Thromboembolic disease • Collagen vascular disease • Thyroid disease • HIV

  31. Chest CT

  32. Chest CT - prone

  33. Esophagram • Thread-like appearance of distal esophagus • Fundus of stomach superior to the diaphragm • No normal peristalsis – movement of feeds only with gravity • Swallow study • Deep laryngeal penetration with thin liquids. • No aspiration with pureeds.

  34. Pulmonary Hypertension • Causes of secondary PAH • Cardiac/Vascular anomaly • Chronic lung disease • Trisomy 21 • Aspiration / reflux • Overcirculation from PDA (repaired at 5 months) • Obstructive sleep apnea • Thromboembolic disease • Collagen vascular disease • Thyroid disease • HIV

  35. Polysomnogram Obstructive Sleep Apnea does not explain PAH Mild sleep-disordered breathing Apnea-hypopnea index of 3 events/hour SpO2 in low 80s in RA SpO2 in mid 90s on ¼ lpm NC (≥92% for 99% of TST)

  36. Pulmonary Hypertension • Causes of secondary PAH • Cardiac/Vascular anomaly • Chronic lung disease • Trisomy 21 • Aspiration / reflux • Overcirculation from PDA (repaired at 5 months) • Obstructive sleep apnea • Thromboembolic disease • Collagen vascular disease • Thyroid disease • HIV

  37. Further laboratories Protein C and S Prothrombin Antithrombin III Lupus Anticoagulant Factor V Leiden Homocysteine Beta 2 GP1 (antiphospholipid) antibodies Cardiolipin IgG and IgM

  38. Pulmonary Hypertension • Causes of secondary PAH • Cardiac/Vascular anomaly • Chronic lung disease • Trisomy 21 • Aspiration / reflux • Overcirculation from PDA (repaired at 5 months) • Obstructive sleep apnea • Thromboembolic disease • Collagen vascular disease • Thyroid disease • HIV

  39. Further laboratories ANA, ESR, CRP TSH and free T4 HIV

  40. Treatment of PAH – Vasodilation and Diuretics Continuous oxygen Oral Sildenafil – started at 0.5 mg/kg/dose and titrated to 2 mg/kg/dose q6h Furosemide 1 mg/kg/dose TID

  41. Thromboembolic disease can contribute to PAH Elevated Beta 2 GP1 antibodies and low antithrombin III Discussed aspirin or coumadin therapy

  42. Patient’s Echo Changes with Therapy

  43. Conclusions • Cause of Pulmonary Hypertension • Chronic lung disease • Primary Aspiration • Trisomy 21 • Overcirculation prior to PDA closure • ?Thromboembolic disease • Cause of increased iron index • Pulmonary Hypertension

  44. Conclusions • Cause of her hypoxia • Pulmonary hypertension • Chronic lung disease • Cause of her cough • Chronic lung disease • Airway protection (aspiration/reflux) • Airway Malacia

  45. Discussion • Open lung biopsy? • Repeat bronchoscopy and BAL?

  46. Outline Case presentation: Cough, Hypoxia, and Down Syndrome Differential Diagnosis of Cough and Hypoxia Multi-system complications of patients with Trisomy 21 Evaluation for Elevated Iron Index and Pulmonary Hypertension Treatment and Monitoring of PAH

More Related